Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227.

Ruxrungtham K, Pedro RJ, Latiff GH, Conradie F, Domingo P, Lupo S, Pumpradit W, Vingerhoets JH, Peeters M, Peeters I, Kakuda TN, De Smedt G, Woodfall B; TMC125-C227 study group.

HIV Med. 2008 Nov;9(10):883-96. doi: 10.1111/j.1468-1293.2008.00644.x. Epub 2008 Sep 14.

2.

Safe treatment interruptions in patients with nadir CD4 counts of more than 350 cells/microL: a randomized trial.

Krolewiecki AJ, Zala C, Vanzulli C, Pérez H, Iannella Mdel C, Bouzas MB, Gun A, Valiente J, Cassetti I, Cahn P.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):425-9.

PMID:
16652049

Supplemental Content

Loading ...
Support Center